US HB4262 | 2011-2012 | 112th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on March 26 2012 - 25% progression, died in committee
Action: 2012-03-30 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 26 2012 - 25% progression, died in committee
Action: 2012-03-30 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Cosmetics Safety Enhancement Act of 2012 - Amends the the Federal Food, Drug, and Cosmetic Act to require the registration of cosmetic products and cosmetic manufacturing facilities, including, for each product: (1) a unique facility identifier, (2) every product's brand name, and (3) product ingredients. Sets registration fees. Requires a cosmetic manufacturer: (1) before the introduction into interstate commerce of a cosmetic product, to establish a file containing scientific evidence substantiating the product's safety; (2) to report any serious adverse event information received that is associated with the use of a cosmetic product; and (3) maintain records concerning any cosmetic product that may be adulterated, misbranded, or otherwise in violation of the Act, including all records relating to cosmetic product safety substantiation or relating to serious adverse event reports. Deems a cosmetic product adulterated if its manufacture, packing, or holding do not conform to current good manufacturing practice regulations. Provides each manufacturer with an opportunity to cease distribution and recall of a cosmetic product if it is determined that there is a reasonable probability that the product is adulterated and the use of, or exposure to, such product will cause serious adverse health consequences or death to humans. Permits the issuance of an order requiring a recall if there is not a voluntary recall of an adulterated product.
Title
Cosmetics Safety Enhancement Act of 2012
Sponsors
Rep. Frank Pallone [D-NJ] | Rep. John Dingell [D-MI] |
History
Date | Chamber | Action |
---|---|---|
2012-03-30 | House | Referred to the Subcommittee on Health. |
2012-03-26 | House | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
HB14 (Related) 2012-03-21 - Referred to House Foreign Affairs
Subjects
Administrative law and regulatory procedures
Administrative remedies
Business records
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Government information and archives
Health
Health information and medical records
Licensing and registrations
Manufacturing
Product safety and quality
Retail and wholesale trades
User charges and fees
Administrative remedies
Business records
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Government information and archives
Health
Health information and medical records
Licensing and registrations
Manufacturing
Product safety and quality
Retail and wholesale trades
User charges and fees
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/112th-congress/house-bill/4262/all-info |
Text | https://www.congress.gov/112/bills/hr4262/BILLS-112hr4262ih.pdf |